Solid dosage form of pre-drug derivative containing ubenimex and preparation method thereof
The invention relates to the field of medicinal chemistry, and discloses a solid dosage form of a pre-drug derivative containing ubenimex and a preparation method thereof. The solid dosage form of thepre-drug derivative containing ubenimex contains, with the total weight of the solid agent type pre-...
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | Chinese English |
Published |
19.04.2019
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The invention relates to the field of medicinal chemistry, and discloses a solid dosage form of a pre-drug derivative containing ubenimex and a preparation method thereof. The solid dosage form of thepre-drug derivative containing ubenimex contains, with the total weight of the solid agent type pre-drug derivative being a reference, 20-80% of a medicinal active component, 10-70% of a filling agent, 0.5-5% of a disintegrating agent and 0.5-5% of a lubricating agent, wherein the medicinal active component is the pre-drug derivative containing ubenimex or a mixture of an optical isomer, diastereoisomer and a racemate of the pre-drug derivative containing ubenimex and pharmaceutically acceptable salt of the pre-drug derivative containing ubenimex. The solid dosage form can prolong the retaining time of the drug in a body, improve pharmacokinetics properties of the drug and improve the biological availability of the drug, and therefore a better anti-tumor effect is realized.
本发明涉及药物化学领域,公开了种含乌苯美司的前药衍生物的固体剂型及其制备方法。 |
---|---|
Bibliography: | Application Number: CN201811574571 |